Stay updated on IMM-101 Combo with Checkpoint Inhibitor in Melanoma Clinical Trial
Sign up to get notified when there's something new on the IMM-101 Combo with Checkpoint Inhibitor in Melanoma Clinical Trial page.

Latest updates to the IMM-101 Combo with Checkpoint Inhibitor in Melanoma Clinical Trial page
- Check6 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the usual study-record content and indicating that access to the record is blocked.SummaryDifference18%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedMelanoma was added to the related topics list and a related topic 'MedlinePlus Genetics' was added. These changes expand the page's topical metadata to improve discoverability and linkage to disease and genetics resources without modifying study details.SummaryDifference0.2%

- Check28 days agoChange DetectedThe page revision was updated to v3.6.6, replacing the previous v3.6.5. This indicates a minor maintenance update to the page without altering study data or visible user-facing information.SummaryDifference0.1%

- Check34 days agoChange DetectedMelanoma and the MedlinePlus Genetics related topic were removed from the page's MeSH/Topics section, narrowing the study's indexed topics. This change affects how the study is surfaced in topic-based navigation and search, without altering the underlying study details.SummaryDifference0.2%

- Check49 days agoChange DetectedNew topic labels include Melanoma and related topics such as MedlinePlus Genetics. The site revision indicator in the footer was updated from v3.6.4 to v3.6.5.SummaryDifference0.2%

- Check56 days agoChange DetectedThe related topics section now excludes Melanoma and MedlinePlus Genetics, reducing disease- and genetics-related references in the study's navigational context.SummaryDifference0.2%

Stay in the know with updates to IMM-101 Combo with Checkpoint Inhibitor in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMM-101 Combo with Checkpoint Inhibitor in Melanoma Clinical Trial page.